COVID-19 monoclonal antibody treatment impact on symptoms and post-COVID conditions among high-risk patients at a Federally Qualified Health Center.
Vawter NL, Godino JG, Lewis SV, Northrup AW, Samaniego JC, Poblete JY, Guereca JA, Sharp SP, Matthews E, Crespo NC, Lucatero PG, Vidaurrazaga MM, Ramers CB. COVID-19 monoclonal antibody treatment impact on symptoms and post-COVID conditions among high-risk patients at a Federally Qualified Health Center. BMC Infect Dis. 2023 Feb 22; 23(1):105.